0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Sodium Etidronate in the Treatment of Paget's Disease of Bone: A Study of Long-Term Results

M. R. A. KHAIRI, M.D.; R. D. ALTMAN, M.D., F.A.C.P.; G. P. DeROSA, M.D.; J. ZIMMERMANN, M.D.; R. K. SCHENK, M.D.; and C. C. JOHNSTON, M.D., F.A.C.P.
[+] Article and Author Information

Grant support: in part by Public Health Service Grants AMO7126, CRCRR00750, and 5MOIRR-261-11.

▸Requests for reprints should be addressed to: Dr. M.R.A. Khairi, Indiana University School of Medicine, 1100 West Michigan Street, Emerson Hall— Room 421, Indianapolis, IN 46202


Indianapolis, Indiana


Ann Intern Med. 1977;87(6):656-663. doi:10.7326/0003-4819-87-6-656
Text Size: A A A

Subjects (109) with symptomatic Paget's disease of bone were treated with 5, 10, or 20 mg of sodium etidronate (EHDP)/kg body weight day for 6 to 24 months. Significant decreases in serum alkaline phosphatase and urinary hydroxyproline were noted after 6 months of therapy; no significant further improvement resulted after prolonged therapy. Some patients maintained biochemical remission after withdrawal of EHDP but others showed a relapse, related primarily to the pretreatment severity. Clinical improvement was noted in 61% of the patients. Similar findings were seen after a second course of EHDP. No side-effects were noted in patients treated with 5 mg of EHDP/kg body weight day. In patients treated with 10 or 20 mg of EHDP/kg body weight day, severe diarrhea, bone pain, and nontraumatic fractures were noted in 3, 13, and 12 patients respectively. Quantitative histomorphometry showed mineralization delay in patients receiving 10 or 20 mg of EHDP/kg body weight day but not in those receiving 5 mg/kg body weight day. Five milligrams of EHDP/kg body weight day was effective and appears to be safer than the higher doses.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)